Literature DB >> 1880686

Proliposomes of indomethacin for oral administration.

O P Katare1, S P Vyas, V K Dixit.   

Abstract

Indomethacin, a non-steroidal anti-inflammatory drug was encapsulated into liposomes composed of soyabean lecithin, cholesterol and stearylamine for oral administration. Liposomes of homogenous size distribution and higher entrapment efficiency were derived from effervescent granule based proliposomes. The efficacy of the oral route was studied by measuring ulcerogenic index and anti-inflammatory activity using carrageenan induced paw oedema test in rats. The effervescent granule based liposomal products exhibited improved in vivo performance with reference to their cytoprotective and anti-inflammatory activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880686     DOI: 10.3109/02652049109021852

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  5 in total

1.  Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.

Authors:  P Kaufmann-Kolle; J Drevs; M R Berger; J Kötting; N Marschner; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac.

Authors:  Vandana Gupta; Ashok K Barupal; Suman Ramteke
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

3.  Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.

Authors:  Jong Chan Byeon; Sang-Eun Lee; Tae-Hyeon Kim; Jung Bin Ahn; Dong-Hyun Kim; Jin-Seok Choi; Jeong-Sook Park
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 4.  Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods.

Authors:  Nasir Javaid; Farzana Yasmeen; Sangdun Choi
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 5.  Insoluble drug delivery strategies: review of recent advances and business prospects.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Acta Pharm Sin B       Date:  2015-08-24       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.